CY1790A - Purification of recombinant hepatitis B surface antigen - Google Patents

Purification of recombinant hepatitis B surface antigen

Info

Publication number: CY1790A
Authority: CY; Cyprus
Prior art keywords: antigen; purification; surface antigen; yeast; daltons
Prior art date: 1987-03-09

Application number

CY179095A

Other languages

English (en)

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-09

Filing date

1995-10-20

Publication date

1995-10-20

1995-10-20 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1995-10-20 Publication of CY1790A publication Critical patent/CY1790A/xx

Links

239000000427 antigen Substances 0.000 title abstract 4
102000036639 antigens Human genes 0.000 title abstract 4
108091007433 antigens Proteins 0.000 title abstract 4
208000002672 hepatitis B Diseases 0.000 title 1
238000000746 purification Methods 0.000 title 1
108010058643 Fungal Proteins Proteins 0.000 abstract 2
230000003196 chaotropic effect Effects 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
239000012510 hollow fiber Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

CY179095A 1987-03-09 1995-10-20 Purification of recombinant hepatitis B surface antigen CY1790A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2334787A	1987-03-09	1987-03-09

Publications (1)

Publication Number	Publication Date
CY1790A true CY1790A (en)	1995-10-20

Family

ID=21814559

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY179095A CY1790A (en)	1987-03-09	1995-10-20	Purification of recombinant hepatitis B surface antigen

Country Status (10)

Country	Link
EP (1)	EP0291146B1 (de)
JP (1)	JPS63270629A (de)
AT (1)	ATE93891T1 (de)
AU (1)	AU608813B2 (de)
CA (1)	CA1304887C (de)
CY (1)	CY1790A (de)
DE (1)	DE3883596T2 (de)
DK (1)	DK123288A (de)
ES (1)	ES2043808T3 (de)
HK (1)	HK48094A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR960023066A (ko) *	1994-12-10	1996-07-18	성재갑	전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL69202A (en) *	1982-09-08	1991-08-16	Smith Kline Rit	Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
EP0171908A3 (de) *	1984-07-11	1987-07-15	Takeda Chemical Industries, Ltd.	Hepatitis-B-Virus-Oberflächenantigen und dessen Herstellung
US4895800A (en) *	1985-11-26	1990-01-23	Phillips Petroleum Company	Yeast production of hepatitis B surface antigen
JPS62298536A (ja) *	1986-06-17	1987-12-25	Green Cross Corp:The	生理活性物質の自動精製方法および自動精製装置
ATE91304T1 (de) *	1987-02-27	1993-07-15	Merck & Co Inc	Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

1988
- 1988-03-01 AT AT88301779T patent/ATE93891T1/de active
- 1988-03-01 EP EP88301779A patent/EP0291146B1/de not_active Expired - Lifetime
- 1988-03-01 ES ES88301779T patent/ES2043808T3/es not_active Expired - Lifetime
- 1988-03-01 DE DE88301779T patent/DE3883596T2/de not_active Expired - Fee Related
- 1988-03-08 CA CA000560864A patent/CA1304887C/en not_active Expired - Lifetime
- 1988-03-08 AU AU12778/88A patent/AU608813B2/en not_active Ceased
- 1988-03-08 DK DK123288A patent/DK123288A/da not_active Application Discontinuation
- 1988-03-09 JP JP63055919A patent/JPS63270629A/ja active Pending
1994
- 1994-05-12 HK HK48094A patent/HK48094A/xx unknown
1995
- 1995-10-20 CY CY179095A patent/CY1790A/xx unknown

Also Published As

Publication number	Publication date
DK123288D0 (da)	1988-03-08
EP0291146A2 (de)	1988-11-17
DE3883596D1 (de)	1993-10-07
ES2043808T3 (es)	1994-01-01
EP0291146A3 (en)	1989-12-06
EP0291146B1 (de)	1993-09-01
ATE93891T1 (de)	1993-09-15
JPS63270629A (ja)	1988-11-08
DK123288A (da)	1988-09-10
DE3883596T2 (de)	1994-02-17
AU608813B2 (en)	1991-04-18
AU1277888A (en)	1988-09-08
CA1304887C (en)	1992-07-07
HK48094A (en)	1994-05-20

Similar Documents

Publication	Publication Date	Title
ATE224956T1 (de)	2002-10-15	Verfahren zur verstärkten expression von virusproteinen
ATE187775T1 (de)	2000-01-15	Verfahren zur herstellung von menschlichem serumalbumin in hefe
ATE373010T1 (de)	2007-09-15	Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
WO1989009787A3 (en)	1990-02-08	Osteogenic devices
ATE173275T1 (de)	1998-11-15	Von einem retrovirus aus der hiv-gruppe abgeleitete peptide und deren verwendung
EP0259475A4 (de)	1989-10-12	Rekombinanter menschlicher endothelzellenwachstumsfaktor.
IL90035A (en)	1990-11-05	Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
EP0401941A3 (de)	1991-04-17	Hepatitis B-Virus-Oberflächen-Antigen und seine Herstellung
EP0423224A4 (en)	1991-11-06	Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
ZA893440B (en)	1990-01-31	Expression of hepatitis b s and pres2 proteins in methylotrophic yeasts
ATE6402T1 (de)	1984-03-15	Verfahren zur herstellung von hepatitis b oberflaechenantigen.
AU605155B2 (en)	1991-01-10	A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof
ATE243755T1 (de)	2003-07-15	Rekombinente adenoviren-impfstoffe
EP0291146A3 (en)	1989-12-06	Purification of recombinant hepatitis b surface antigen
IL88377A0 (en)	1989-06-30	Molecular cloning of the human interferon type 1 receptor
ATE209252T1 (de)	2001-12-15	Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
ES2078229T3 (es)	1995-12-16	Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
EP0433378A4 (en)	1991-11-06	Allelic variants of -i(plasmodium falciparum) merozoite surface antigen
NZ230996A (en)	1991-09-25	Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
EP0293201A3 (de)	1990-02-28	Methode zur Impfung gegen Hepatitis-B-Virus
EP0183272A3 (en)	1988-01-20	Vector capable of efficient gene expression and utilization of such vector
DE68917520D1 (de)	1994-09-22	Verfahren und Systeme zur Herstellung von HIV-Antigenen.
PT89041A (pt)	1988-12-01	Metodo de preparacao de diagnosticos e vacinas nanbv
MY106940A (en)	1995-08-30	Allelic variants of plasmodium falciparum merozoite surface antigen.